nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—hypertension—obesity	0.391	1	CtDrD
Betaxolol—ADRB1—obesity	0.129	0.543	CbGaD
Betaxolol—ADRB2—obesity	0.108	0.457	CbGaD
Betaxolol—ADRB2—Phenylpropanolamine—obesity	0.0629	0.254	CbGbCtD
Betaxolol—ADRB1—Phenylpropanolamine—obesity	0.0619	0.25	CbGbCtD
Betaxolol—CYP1A2—Phentermine—obesity	0.0201	0.081	CbGbCtD
Betaxolol—CYP1A2—Phenylpropanolamine—obesity	0.0191	0.0773	CbGbCtD
Betaxolol—CYP1A2—Bupropion—obesity	0.0171	0.0689	CbGbCtD
Betaxolol—CYP2D6—Phentermine—obesity	0.0165	0.0667	CbGbCtD
Betaxolol—CYP2D6—Bupropion—obesity	0.0141	0.0567	CbGbCtD
Betaxolol—CYP2D6—Methamphetamine—obesity	0.0132	0.0533	CbGbCtD
Betaxolol—CYP1A2—Cimetidine—obesity	0.0125	0.0505	CbGbCtD
Betaxolol—CYP2D6—Cimetidine—obesity	0.0103	0.0416	CbGbCtD
Betaxolol—Alprenolol—ADRB3—obesity	0.000211	0.0743	CrCbGaD
Betaxolol—Practolol—ADRB1—obesity	0.000182	0.0639	CrCbGaD
Betaxolol—Pindolol—ADRB3—obesity	0.000182	0.0639	CrCbGaD
Betaxolol—Acebutolol—SLC22A1—obesity	0.000139	0.0487	CrCbGaD
Betaxolol—Esmolol—ADRB1—obesity	0.000131	0.0459	CrCbGaD
Betaxolol—Atenolol—ADRB1—obesity	0.000114	0.0401	CrCbGaD
Betaxolol—Chlorphenesin—CYP19A1—obesity	0.000112	0.0393	CrCbGaD
Betaxolol—Chlorphenesin—BCHE—obesity	0.000111	0.0392	CrCbGaD
Betaxolol—Bisoprolol—ADRB1—obesity	0.000111	0.039	CrCbGaD
Betaxolol—Esmolol—ADRB2—obesity	0.00011	0.0386	CrCbGaD
Betaxolol—Acebutolol—ADRB1—obesity	0.000105	0.037	CrCbGaD
Betaxolol—Oxprenolol—ADRB1—obesity	0.000104	0.0367	CrCbGaD
Betaxolol—Propranolol—ADRB3—obesity	9.91e-05	0.0348	CrCbGaD
Betaxolol—Atenolol—ADRB2—obesity	9.58e-05	0.0337	CrCbGaD
Betaxolol—Alprenolol—ADRB1—obesity	9.55e-05	0.0336	CrCbGaD
Betaxolol—Bisoprolol—ADRB2—obesity	9.34e-05	0.0328	CrCbGaD
Betaxolol—Pindolol—HTR1B—obesity	9.29e-05	0.0327	CrCbGaD
Betaxolol—Metoprolol—ADRB1—obesity	8.88e-05	0.0312	CrCbGaD
Betaxolol—Acebutolol—ADRB2—obesity	8.84e-05	0.0311	CrCbGaD
Betaxolol—Oxprenolol—ADRB2—obesity	8.78e-05	0.0309	CrCbGaD
Betaxolol—Pindolol—ADRB1—obesity	8.21e-05	0.0289	CrCbGaD
Betaxolol—Alprenolol—ADRB2—obesity	8.03e-05	0.0282	CrCbGaD
Betaxolol—Metoprolol—ADRB2—obesity	7.47e-05	0.0263	CrCbGaD
Betaxolol—Vertigo—Orlistat—obesity	7.46e-05	0.000867	CcSEcCtD
Betaxolol—Ill-defined disorder—Sibutramine—obesity	7.45e-05	0.000867	CcSEcCtD
Betaxolol—Anaemia—Sibutramine—obesity	7.43e-05	0.000863	CcSEcCtD
Betaxolol—Osteoarthritis—Topiramate—obesity	7.41e-05	0.000862	CcSEcCtD
Betaxolol—Disturbance in sexual arousal—Topiramate—obesity	7.35e-05	0.000855	CcSEcCtD
Betaxolol—Palpitations—Orlistat—obesity	7.34e-05	0.000853	CcSEcCtD
Betaxolol—Angiopathy—Bupropion—obesity	7.3e-05	0.000849	CcSEcCtD
Betaxolol—Affect lability—Topiramate—obesity	7.29e-05	0.000848	CcSEcCtD
Betaxolol—Nausea—Cimetidine—obesity	7.29e-05	0.000848	CcSEcCtD
Betaxolol—Immune system disorder—Bupropion—obesity	7.27e-05	0.000845	CcSEcCtD
Betaxolol—Mediastinal disorder—Bupropion—obesity	7.25e-05	0.000843	CcSEcCtD
Betaxolol—Malaise—Sibutramine—obesity	7.24e-05	0.000842	CcSEcCtD
Betaxolol—Cough—Orlistat—obesity	7.24e-05	0.000842	CcSEcCtD
Betaxolol—Psychotic disorder—Topiramate—obesity	7.24e-05	0.000841	CcSEcCtD
Betaxolol—Chills—Bupropion—obesity	7.22e-05	0.000839	CcSEcCtD
Betaxolol—Vertigo—Sibutramine—obesity	7.22e-05	0.000839	CcSEcCtD
Betaxolol—Syncope—Sibutramine—obesity	7.2e-05	0.000838	CcSEcCtD
Betaxolol—Arrhythmia—Bupropion—obesity	7.19e-05	0.000836	CcSEcCtD
Betaxolol—Alopecia—Bupropion—obesity	7.11e-05	0.000827	CcSEcCtD
Betaxolol—Palpitations—Sibutramine—obesity	7.1e-05	0.000826	CcSEcCtD
Betaxolol—Chest pain—Orlistat—obesity	7.07e-05	0.000822	CcSEcCtD
Betaxolol—Myalgia—Orlistat—obesity	7.07e-05	0.000822	CcSEcCtD
Betaxolol—Loss of consciousness—Sibutramine—obesity	7.06e-05	0.000821	CcSEcCtD
Betaxolol—Mental disorder—Bupropion—obesity	7.05e-05	0.00082	CcSEcCtD
Betaxolol—Anxiety—Orlistat—obesity	7.04e-05	0.000819	CcSEcCtD
Betaxolol—Mood swings—Topiramate—obesity	7.02e-05	0.000816	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	7.02e-05	0.000816	CcSEcCtD
Betaxolol—Cough—Sibutramine—obesity	7.01e-05	0.000815	CcSEcCtD
Betaxolol—Malnutrition—Bupropion—obesity	7e-05	0.000814	CcSEcCtD
Betaxolol—Discomfort—Orlistat—obesity	6.98e-05	0.000812	CcSEcCtD
Betaxolol—Ataxia—Topiramate—obesity	6.97e-05	0.00081	CcSEcCtD
Betaxolol—Dry mouth—Orlistat—obesity	6.91e-05	0.000804	CcSEcCtD
Betaxolol—Pindolol—ADRB2—obesity	6.91e-05	0.0243	CrCbGaD
Betaxolol—Tension—Bupropion—obesity	6.87e-05	0.000799	CcSEcCtD
Betaxolol—Dysgeusia—Bupropion—obesity	6.86e-05	0.000798	CcSEcCtD
Betaxolol—Chest pain—Sibutramine—obesity	6.84e-05	0.000795	CcSEcCtD
Betaxolol—Myalgia—Sibutramine—obesity	6.84e-05	0.000795	CcSEcCtD
Betaxolol—Arthralgia—Sibutramine—obesity	6.84e-05	0.000795	CcSEcCtD
Betaxolol—Anxiety—Sibutramine—obesity	6.82e-05	0.000793	CcSEcCtD
Betaxolol—Nervousness—Bupropion—obesity	6.8e-05	0.000791	CcSEcCtD
Betaxolol—Oedema—Orlistat—obesity	6.77e-05	0.000788	CcSEcCtD
Betaxolol—Discomfort—Sibutramine—obesity	6.76e-05	0.000786	CcSEcCtD
Betaxolol—Hypokalaemia—Topiramate—obesity	6.74e-05	0.000784	CcSEcCtD
Betaxolol—Muscle spasms—Bupropion—obesity	6.73e-05	0.000783	CcSEcCtD
Betaxolol—Infection—Orlistat—obesity	6.73e-05	0.000783	CcSEcCtD
Betaxolol—Breast disorder—Topiramate—obesity	6.7e-05	0.000779	CcSEcCtD
Betaxolol—Dry mouth—Sibutramine—obesity	6.69e-05	0.000778	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Topiramate—obesity	6.67e-05	0.000776	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Topiramate—obesity	6.67e-05	0.000776	CcSEcCtD
Betaxolol—Nervous system disorder—Orlistat—obesity	6.64e-05	0.000773	CcSEcCtD
Betaxolol—Nasopharyngitis—Topiramate—obesity	6.63e-05	0.00077	CcSEcCtD
Betaxolol—Confusional state—Sibutramine—obesity	6.61e-05	0.000769	CcSEcCtD
Betaxolol—Vision blurred—Bupropion—obesity	6.6e-05	0.000768	CcSEcCtD
Betaxolol—Skin disorder—Orlistat—obesity	6.58e-05	0.000765	CcSEcCtD
Betaxolol—Tremor—Bupropion—obesity	6.56e-05	0.000763	CcSEcCtD
Betaxolol—Oedema—Sibutramine—obesity	6.56e-05	0.000762	CcSEcCtD
Betaxolol—Hyperhidrosis—Orlistat—obesity	6.55e-05	0.000762	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Topiramate—obesity	6.53e-05	0.00076	CcSEcCtD
Betaxolol—Infection—Sibutramine—obesity	6.51e-05	0.000757	CcSEcCtD
Betaxolol—Ill-defined disorder—Bupropion—obesity	6.5e-05	0.000756	CcSEcCtD
Betaxolol—Anaemia—Bupropion—obesity	6.47e-05	0.000753	CcSEcCtD
Betaxolol—Shock—Sibutramine—obesity	6.45e-05	0.00075	CcSEcCtD
Betaxolol—Thrombocytopenia—Sibutramine—obesity	6.42e-05	0.000746	CcSEcCtD
Betaxolol—Asthma—Topiramate—obesity	6.4e-05	0.000745	CcSEcCtD
Betaxolol—Dysphagia—Topiramate—obesity	6.4e-05	0.000745	CcSEcCtD
Betaxolol—Tachycardia—Sibutramine—obesity	6.4e-05	0.000744	CcSEcCtD
Betaxolol—Skin disorder—Sibutramine—obesity	6.37e-05	0.000741	CcSEcCtD
Betaxolol—Hyperhidrosis—Sibutramine—obesity	6.34e-05	0.000737	CcSEcCtD
Betaxolol—Malaise—Bupropion—obesity	6.32e-05	0.000734	CcSEcCtD
Betaxolol—Vertigo—Bupropion—obesity	6.29e-05	0.000732	CcSEcCtD
Betaxolol—Syncope—Bupropion—obesity	6.28e-05	0.00073	CcSEcCtD
Betaxolol—Anorexia—Sibutramine—obesity	6.25e-05	0.000727	CcSEcCtD
Betaxolol—Angina pectoris—Topiramate—obesity	6.24e-05	0.000725	CcSEcCtD
Betaxolol—Palpitations—Bupropion—obesity	6.19e-05	0.00072	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Orlistat—obesity	6.17e-05	0.000718	CcSEcCtD
Betaxolol—Bronchitis—Topiramate—obesity	6.16e-05	0.000716	CcSEcCtD
Betaxolol—Loss of consciousness—Bupropion—obesity	6.16e-05	0.000716	CcSEcCtD
Betaxolol—Insomnia—Orlistat—obesity	6.13e-05	0.000713	CcSEcCtD
Betaxolol—Hypotension—Sibutramine—obesity	6.13e-05	0.000712	CcSEcCtD
Betaxolol—Cough—Bupropion—obesity	6.11e-05	0.000711	CcSEcCtD
Betaxolol—Paraesthesia—Orlistat—obesity	6.08e-05	0.000707	CcSEcCtD
Betaxolol—Dysuria—Topiramate—obesity	5.99e-05	0.000696	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Sibutramine—obesity	5.97e-05	0.000695	CcSEcCtD
Betaxolol—Dyspepsia—Orlistat—obesity	5.96e-05	0.000693	CcSEcCtD
Betaxolol—Myalgia—Bupropion—obesity	5.96e-05	0.000693	CcSEcCtD
Betaxolol—Arthralgia—Bupropion—obesity	5.96e-05	0.000693	CcSEcCtD
Betaxolol—Chest pain—Bupropion—obesity	5.96e-05	0.000693	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Topiramate—obesity	5.95e-05	0.000692	CcSEcCtD
Betaxolol—Anxiety—Bupropion—obesity	5.94e-05	0.000691	CcSEcCtD
Betaxolol—Insomnia—Sibutramine—obesity	5.93e-05	0.00069	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	5.92e-05	0.000689	CcSEcCtD
Betaxolol—Erectile dysfunction—Topiramate—obesity	5.9e-05	0.000686	CcSEcCtD
Betaxolol—Discomfort—Bupropion—obesity	5.89e-05	0.000685	CcSEcCtD
Betaxolol—Decreased appetite—Orlistat—obesity	5.89e-05	0.000685	CcSEcCtD
Betaxolol—Paraesthesia—Sibutramine—obesity	5.89e-05	0.000685	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Orlistat—obesity	5.85e-05	0.00068	CcSEcCtD
Betaxolol—Dyspnoea—Sibutramine—obesity	5.85e-05	0.00068	CcSEcCtD
Betaxolol—Fatigue—Orlistat—obesity	5.84e-05	0.000679	CcSEcCtD
Betaxolol—Dry mouth—Bupropion—obesity	5.83e-05	0.000678	CcSEcCtD
Betaxolol—Weight increased—Topiramate—obesity	5.83e-05	0.000678	CcSEcCtD
Betaxolol—Weight decreased—Topiramate—obesity	5.79e-05	0.000674	CcSEcCtD
Betaxolol—Pain—Orlistat—obesity	5.79e-05	0.000674	CcSEcCtD
Betaxolol—Hyperglycaemia—Topiramate—obesity	5.78e-05	0.000672	CcSEcCtD
Betaxolol—Dyspepsia—Sibutramine—obesity	5.77e-05	0.000671	CcSEcCtD
Betaxolol—Confusional state—Bupropion—obesity	5.76e-05	0.00067	CcSEcCtD
Betaxolol—Pneumonia—Topiramate—obesity	5.74e-05	0.000668	CcSEcCtD
Betaxolol—Oedema—Bupropion—obesity	5.72e-05	0.000665	CcSEcCtD
Betaxolol—Infestation NOS—Topiramate—obesity	5.71e-05	0.000664	CcSEcCtD
Betaxolol—Infestation—Topiramate—obesity	5.71e-05	0.000664	CcSEcCtD
Betaxolol—Decreased appetite—Sibutramine—obesity	5.7e-05	0.000663	CcSEcCtD
Betaxolol—Depression—Topiramate—obesity	5.69e-05	0.000662	CcSEcCtD
Betaxolol—Infection—Bupropion—obesity	5.68e-05	0.00066	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Sibutramine—obesity	5.66e-05	0.000658	CcSEcCtD
Betaxolol—Shock—Bupropion—obesity	5.62e-05	0.000654	CcSEcCtD
Betaxolol—Pain—Sibutramine—obesity	5.61e-05	0.000652	CcSEcCtD
Betaxolol—Constipation—Sibutramine—obesity	5.61e-05	0.000652	CcSEcCtD
Betaxolol—Nervous system disorder—Bupropion—obesity	5.61e-05	0.000652	CcSEcCtD
Betaxolol—Neuropathy peripheral—Topiramate—obesity	5.6e-05	0.000651	CcSEcCtD
Betaxolol—Thrombocytopenia—Bupropion—obesity	5.6e-05	0.000651	CcSEcCtD
Betaxolol—Feeling abnormal—Orlistat—obesity	5.58e-05	0.000649	CcSEcCtD
Betaxolol—Tachycardia—Bupropion—obesity	5.58e-05	0.000649	CcSEcCtD
Betaxolol—Stomatitis—Topiramate—obesity	5.57e-05	0.000647	CcSEcCtD
Betaxolol—Skin disorder—Bupropion—obesity	5.55e-05	0.000646	CcSEcCtD
Betaxolol—Conjunctivitis—Topiramate—obesity	5.55e-05	0.000645	CcSEcCtD
Betaxolol—Hyperhidrosis—Bupropion—obesity	5.53e-05	0.000643	CcSEcCtD
Betaxolol—Anorexia—Bupropion—obesity	5.45e-05	0.000634	CcSEcCtD
Betaxolol—Feeling abnormal—Sibutramine—obesity	5.4e-05	0.000628	CcSEcCtD
Betaxolol—Epistaxis—Topiramate—obesity	5.39e-05	0.000626	CcSEcCtD
Betaxolol—Urticaria—Orlistat—obesity	5.38e-05	0.000626	CcSEcCtD
Betaxolol—Sinusitis—Topiramate—obesity	5.36e-05	0.000623	CcSEcCtD
Betaxolol—Body temperature increased—Orlistat—obesity	5.36e-05	0.000623	CcSEcCtD
Betaxolol—Hypotension—Bupropion—obesity	5.34e-05	0.000621	CcSEcCtD
Betaxolol—Agranulocytosis—Topiramate—obesity	5.33e-05	0.00062	CcSEcCtD
Betaxolol—Bradycardia—Topiramate—obesity	5.22e-05	0.000607	CcSEcCtD
Betaxolol—Urticaria—Sibutramine—obesity	5.21e-05	0.000606	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Bupropion—obesity	5.21e-05	0.000606	CcSEcCtD
Betaxolol—Body temperature increased—Sibutramine—obesity	5.18e-05	0.000603	CcSEcCtD
Betaxolol—Insomnia—Bupropion—obesity	5.17e-05	0.000601	CcSEcCtD
Betaxolol—Rhinitis—Topiramate—obesity	5.14e-05	0.000598	CcSEcCtD
Betaxolol—Chlorphenesin—PTGS2—obesity	5.14e-05	0.0181	CrCbGaD
Betaxolol—Paraesthesia—Bupropion—obesity	5.13e-05	0.000597	CcSEcCtD
Betaxolol—Hypoaesthesia—Topiramate—obesity	5.1e-05	0.000593	CcSEcCtD
Betaxolol—Hallucination—Topiramate—obesity	5.1e-05	0.000593	CcSEcCtD
Betaxolol—Dyspnoea—Bupropion—obesity	5.1e-05	0.000593	CcSEcCtD
Betaxolol—Pharyngitis—Topiramate—obesity	5.09e-05	0.000592	CcSEcCtD
Betaxolol—Propranolol—HTR1B—obesity	5.07e-05	0.0178	CrCbGaD
Betaxolol—Dyspepsia—Bupropion—obesity	5.03e-05	0.000585	CcSEcCtD
Betaxolol—Hypersensitivity—Orlistat—obesity	4.99e-05	0.00058	CcSEcCtD
Betaxolol—Decreased appetite—Bupropion—obesity	4.97e-05	0.000578	CcSEcCtD
Betaxolol—Visual impairment—Topiramate—obesity	4.94e-05	0.000574	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Bupropion—obesity	4.93e-05	0.000574	CcSEcCtD
Betaxolol—Fatigue—Bupropion—obesity	4.93e-05	0.000573	CcSEcCtD
Betaxolol—Constipation—Bupropion—obesity	4.89e-05	0.000568	CcSEcCtD
Betaxolol—Pain—Bupropion—obesity	4.89e-05	0.000568	CcSEcCtD
Betaxolol—Asthenia—Orlistat—obesity	4.86e-05	0.000565	CcSEcCtD
Betaxolol—Hypersensitivity—Sibutramine—obesity	4.83e-05	0.000562	CcSEcCtD
Betaxolol—Pruritus—Orlistat—obesity	4.79e-05	0.000557	CcSEcCtD
Betaxolol—Eye disorder—Topiramate—obesity	4.79e-05	0.000557	CcSEcCtD
Betaxolol—Tinnitus—Topiramate—obesity	4.78e-05	0.000556	CcSEcCtD
Betaxolol—Cardiac disorder—Topiramate—obesity	4.76e-05	0.000553	CcSEcCtD
Betaxolol—Flushing—Topiramate—obesity	4.76e-05	0.000553	CcSEcCtD
Betaxolol—Feeling abnormal—Bupropion—obesity	4.71e-05	0.000548	CcSEcCtD
Betaxolol—Asthenia—Sibutramine—obesity	4.7e-05	0.000547	CcSEcCtD
Betaxolol—Angiopathy—Topiramate—obesity	4.65e-05	0.000541	CcSEcCtD
Betaxolol—Pruritus—Sibutramine—obesity	4.64e-05	0.000539	CcSEcCtD
Betaxolol—Diarrhoea—Orlistat—obesity	4.64e-05	0.000539	CcSEcCtD
Betaxolol—Immune system disorder—Topiramate—obesity	4.63e-05	0.000538	CcSEcCtD
Betaxolol—Mediastinal disorder—Topiramate—obesity	4.62e-05	0.000537	CcSEcCtD
Betaxolol—Chills—Topiramate—obesity	4.6e-05	0.000535	CcSEcCtD
Betaxolol—Urticaria—Bupropion—obesity	4.54e-05	0.000528	CcSEcCtD
Betaxolol—Alopecia—Topiramate—obesity	4.53e-05	0.000527	CcSEcCtD
Betaxolol—Body temperature increased—Bupropion—obesity	4.52e-05	0.000525	CcSEcCtD
Betaxolol—Mental disorder—Topiramate—obesity	4.49e-05	0.000522	CcSEcCtD
Betaxolol—Diarrhoea—Sibutramine—obesity	4.49e-05	0.000522	CcSEcCtD
Betaxolol—Propranolol—ADRB1—obesity	4.48e-05	0.0158	CrCbGaD
Betaxolol—Dizziness—Orlistat—obesity	4.48e-05	0.000521	CcSEcCtD
Betaxolol—Erythema—Topiramate—obesity	4.46e-05	0.000519	CcSEcCtD
Betaxolol—Malnutrition—Topiramate—obesity	4.46e-05	0.000519	CcSEcCtD
Betaxolol—Tension—Topiramate—obesity	4.38e-05	0.000509	CcSEcCtD
Betaxolol—Dysgeusia—Topiramate—obesity	4.37e-05	0.000508	CcSEcCtD
Betaxolol—Dizziness—Sibutramine—obesity	4.34e-05	0.000504	CcSEcCtD
Betaxolol—Nervousness—Topiramate—obesity	4.33e-05	0.000504	CcSEcCtD
Betaxolol—Vomiting—Orlistat—obesity	4.31e-05	0.000501	CcSEcCtD
Betaxolol—Muscle spasms—Topiramate—obesity	4.29e-05	0.000499	CcSEcCtD
Betaxolol—Rash—Orlistat—obesity	4.27e-05	0.000497	CcSEcCtD
Betaxolol—Dermatitis—Orlistat—obesity	4.27e-05	0.000496	CcSEcCtD
Betaxolol—Headache—Orlistat—obesity	4.24e-05	0.000494	CcSEcCtD
Betaxolol—Hypersensitivity—Bupropion—obesity	4.21e-05	0.00049	CcSEcCtD
Betaxolol—Vision blurred—Topiramate—obesity	4.21e-05	0.000489	CcSEcCtD
Betaxolol—Tremor—Topiramate—obesity	4.18e-05	0.000486	CcSEcCtD
Betaxolol—Vomiting—Sibutramine—obesity	4.17e-05	0.000485	CcSEcCtD
Betaxolol—Ill-defined disorder—Topiramate—obesity	4.14e-05	0.000481	CcSEcCtD
Betaxolol—Rash—Sibutramine—obesity	4.13e-05	0.000481	CcSEcCtD
Betaxolol—Dermatitis—Sibutramine—obesity	4.13e-05	0.00048	CcSEcCtD
Betaxolol—Anaemia—Topiramate—obesity	4.12e-05	0.00048	CcSEcCtD
Betaxolol—Headache—Sibutramine—obesity	4.11e-05	0.000478	CcSEcCtD
Betaxolol—Asthenia—Bupropion—obesity	4.1e-05	0.000477	CcSEcCtD
Betaxolol—Pruritus—Bupropion—obesity	4.04e-05	0.00047	CcSEcCtD
Betaxolol—Nausea—Orlistat—obesity	4.02e-05	0.000468	CcSEcCtD
Betaxolol—Malaise—Topiramate—obesity	4.02e-05	0.000468	CcSEcCtD
Betaxolol—Vertigo—Topiramate—obesity	4.01e-05	0.000466	CcSEcCtD
Betaxolol—Syncope—Topiramate—obesity	4e-05	0.000465	CcSEcCtD
Betaxolol—Palpitations—Topiramate—obesity	3.94e-05	0.000459	CcSEcCtD
Betaxolol—Loss of consciousness—Topiramate—obesity	3.92e-05	0.000456	CcSEcCtD
Betaxolol—Diarrhoea—Bupropion—obesity	3.91e-05	0.000455	CcSEcCtD
Betaxolol—Nausea—Sibutramine—obesity	3.89e-05	0.000453	CcSEcCtD
Betaxolol—Cough—Topiramate—obesity	3.89e-05	0.000453	CcSEcCtD
Betaxolol—Myalgia—Topiramate—obesity	3.8e-05	0.000442	CcSEcCtD
Betaxolol—Chest pain—Topiramate—obesity	3.8e-05	0.000442	CcSEcCtD
Betaxolol—Arthralgia—Topiramate—obesity	3.8e-05	0.000442	CcSEcCtD
Betaxolol—Anxiety—Topiramate—obesity	3.79e-05	0.00044	CcSEcCtD
Betaxolol—Dizziness—Bupropion—obesity	3.78e-05	0.00044	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	3.77e-05	0.000439	CcSEcCtD
Betaxolol—Propranolol—ADRB2—obesity	3.77e-05	0.0133	CrCbGaD
Betaxolol—Discomfort—Topiramate—obesity	3.75e-05	0.000436	CcSEcCtD
Betaxolol—Dry mouth—Topiramate—obesity	3.72e-05	0.000432	CcSEcCtD
Betaxolol—Confusional state—Topiramate—obesity	3.67e-05	0.000427	CcSEcCtD
Betaxolol—Oedema—Topiramate—obesity	3.64e-05	0.000423	CcSEcCtD
Betaxolol—Vomiting—Bupropion—obesity	3.63e-05	0.000423	CcSEcCtD
Betaxolol—Infection—Topiramate—obesity	3.62e-05	0.000421	CcSEcCtD
Betaxolol—Rash—Bupropion—obesity	3.6e-05	0.000419	CcSEcCtD
Betaxolol—Dermatitis—Bupropion—obesity	3.6e-05	0.000419	CcSEcCtD
Betaxolol—Shock—Topiramate—obesity	3.58e-05	0.000417	CcSEcCtD
Betaxolol—Headache—Bupropion—obesity	3.58e-05	0.000416	CcSEcCtD
Betaxolol—Nervous system disorder—Topiramate—obesity	3.57e-05	0.000415	CcSEcCtD
Betaxolol—Thrombocytopenia—Topiramate—obesity	3.57e-05	0.000415	CcSEcCtD
Betaxolol—Tachycardia—Topiramate—obesity	3.55e-05	0.000413	CcSEcCtD
Betaxolol—Skin disorder—Topiramate—obesity	3.54e-05	0.000411	CcSEcCtD
Betaxolol—Hyperhidrosis—Topiramate—obesity	3.52e-05	0.000409	CcSEcCtD
Betaxolol—Anorexia—Topiramate—obesity	3.47e-05	0.000404	CcSEcCtD
Betaxolol—Hypotension—Topiramate—obesity	3.4e-05	0.000396	CcSEcCtD
Betaxolol—Nausea—Bupropion—obesity	3.4e-05	0.000395	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Topiramate—obesity	3.32e-05	0.000386	CcSEcCtD
Betaxolol—Insomnia—Topiramate—obesity	3.29e-05	0.000383	CcSEcCtD
Betaxolol—Paraesthesia—Topiramate—obesity	3.27e-05	0.00038	CcSEcCtD
Betaxolol—Dyspnoea—Topiramate—obesity	3.25e-05	0.000378	CcSEcCtD
Betaxolol—Dyspepsia—Topiramate—obesity	3.21e-05	0.000373	CcSEcCtD
Betaxolol—Decreased appetite—Topiramate—obesity	3.17e-05	0.000368	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Topiramate—obesity	3.14e-05	0.000366	CcSEcCtD
Betaxolol—Fatigue—Topiramate—obesity	3.14e-05	0.000365	CcSEcCtD
Betaxolol—Pain—Topiramate—obesity	3.11e-05	0.000362	CcSEcCtD
Betaxolol—Constipation—Topiramate—obesity	3.11e-05	0.000362	CcSEcCtD
Betaxolol—Feeling abnormal—Topiramate—obesity	3e-05	0.000349	CcSEcCtD
Betaxolol—Urticaria—Topiramate—obesity	2.89e-05	0.000336	CcSEcCtD
Betaxolol—Body temperature increased—Topiramate—obesity	2.88e-05	0.000335	CcSEcCtD
Betaxolol—Hypersensitivity—Topiramate—obesity	2.68e-05	0.000312	CcSEcCtD
Betaxolol—Asthenia—Topiramate—obesity	2.61e-05	0.000304	CcSEcCtD
Betaxolol—Pruritus—Topiramate—obesity	2.58e-05	0.0003	CcSEcCtD
Betaxolol—Diarrhoea—Topiramate—obesity	2.49e-05	0.00029	CcSEcCtD
Betaxolol—Dizziness—Topiramate—obesity	2.41e-05	0.00028	CcSEcCtD
Betaxolol—Vomiting—Topiramate—obesity	2.32e-05	0.000269	CcSEcCtD
Betaxolol—Rash—Topiramate—obesity	2.3e-05	0.000267	CcSEcCtD
Betaxolol—Dermatitis—Topiramate—obesity	2.29e-05	0.000267	CcSEcCtD
Betaxolol—Headache—Topiramate—obesity	2.28e-05	0.000265	CcSEcCtD
Betaxolol—Nausea—Topiramate—obesity	2.16e-05	0.000252	CcSEcCtD
Betaxolol—ADRB1—Signaling Pathways—SOCS3—obesity	4.8e-06	0.000138	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—obesity	4.77e-06	0.000137	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SOCS1—obesity	4.76e-06	0.000136	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CLOCK—obesity	4.73e-06	0.000136	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC22A1—obesity	4.73e-06	0.000136	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CD—obesity	4.71e-06	0.000135	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ACP5—obesity	4.71e-06	0.000135	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GNB3—obesity	4.7e-06	0.000135	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SOCS3—obesity	4.7e-06	0.000135	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—obesity	4.65e-06	0.000133	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—TYK2—obesity	4.64e-06	0.000133	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	4.63e-06	0.000133	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF2—obesity	4.62e-06	0.000132	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SULT2A1—obesity	4.61e-06	0.000132	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GLP1R—obesity	4.61e-06	0.000132	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GNB3—obesity	4.6e-06	0.000132	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—RHOA—obesity	4.6e-06	0.000132	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—G6PD—obesity	4.59e-06	0.000132	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GNAS—obesity	4.58e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3R1—obesity	4.55e-06	0.00013	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SREBF2—obesity	4.54e-06	0.00013	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HK1—obesity	4.54e-06	0.00013	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—DPYD—obesity	4.54e-06	0.00013	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—TYK2—obesity	4.54e-06	0.00013	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—obesity	4.53e-06	0.00013	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	4.52e-06	0.00013	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF2—obesity	4.52e-06	0.000129	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—RHOA—obesity	4.5e-06	0.000129	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOB—obesity	4.48e-06	0.000129	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GNAS—obesity	4.48e-06	0.000128	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3R1—obesity	4.45e-06	0.000128	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOB—obesity	4.39e-06	0.000126	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPA—obesity	4.38e-06	0.000126	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL5—obesity	4.38e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PRKAR2B—obesity	4.37e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—DCN—obesity	4.34e-06	0.000124	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPIN1—obesity	4.29e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL5—obesity	4.28e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LPL—obesity	4.28e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FOXO1—obesity	4.25e-06	0.000122	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	4.24e-06	0.000122	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CPT1A—obesity	4.22e-06	0.000121	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—obesity	4.21e-06	0.000121	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA5—obesity	4.2e-06	0.00012	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	4.2e-06	0.00012	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LPL—obesity	4.19e-06	0.00012	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FOXO1—obesity	4.16e-06	0.000119	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	4.15e-06	0.000119	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NAMPT—obesity	4.14e-06	0.000119	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LIPC—obesity	4.11e-06	0.000118	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCK—obesity	4.11e-06	0.000118	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	4.11e-06	0.000118	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOC3—obesity	4.08e-06	0.000117	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	4.08e-06	0.000117	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CLOCK—obesity	4.01e-06	0.000115	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC22A1—obesity	4.01e-06	0.000115	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	4e-06	0.000115	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CETP—obesity	3.97e-06	0.000114	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	3.96e-06	0.000114	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	3.95e-06	0.000113	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCD—obesity	3.94e-06	0.000113	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SDC1—obesity	3.92e-06	0.000112	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SULT2A1—obesity	3.91e-06	0.000112	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GLP1R—obesity	3.91e-06	0.000112	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2A—obesity	3.86e-06	0.000111	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCD—obesity	3.86e-06	0.000111	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKR1C3—obesity	3.86e-06	0.000111	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—C3—obesity	3.85e-06	0.00011	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—DPYD—obesity	3.84e-06	0.00011	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SCARB1—obesity	3.8e-06	0.000109	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2A—obesity	3.78e-06	0.000108	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—C3—obesity	3.77e-06	0.000108	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PRKAR2B—obesity	3.7e-06	0.000106	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SREBF1—obesity	3.69e-06	0.000106	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—DCN—obesity	3.67e-06	0.000105	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IRS2—obesity	3.67e-06	0.000105	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AGT—obesity	3.66e-06	0.000105	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	3.61e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LEP—obesity	3.59e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOE—obesity	3.59e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IRS2—obesity	3.59e-06	0.000103	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GOT2—obesity	3.59e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AGT—obesity	3.58e-06	0.000103	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CPT1A—obesity	3.57e-06	0.000102	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CAV1—obesity	3.56e-06	0.000102	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOA1—obesity	3.55e-06	0.000102	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOE—obesity	3.51e-06	0.000101	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LEP—obesity	3.51e-06	0.000101	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—FASN—obesity	3.51e-06	0.000101	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NAMPT—obesity	3.5e-06	0.0001	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—BCHE—obesity	3.49e-06	0.0001	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	3.48e-06	9.98e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LIPC—obesity	3.48e-06	9.98e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCK—obesity	3.48e-06	9.98e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CAV1—obesity	3.48e-06	9.97e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOA1—obesity	3.47e-06	9.95e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOC3—obesity	3.46e-06	9.92e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	3.44e-06	9.85e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ESR1—obesity	3.43e-06	9.82e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCB—obesity	3.38e-06	9.7e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—F2—obesity	3.38e-06	9.7e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP2E1—obesity	3.37e-06	9.66e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CETP—obesity	3.36e-06	9.63e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ESR1—obesity	3.35e-06	9.61e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—BAD—obesity	3.34e-06	9.58e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NQO1—obesity	3.33e-06	9.56e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SDC1—obesity	3.32e-06	9.52e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCB—obesity	3.31e-06	9.49e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—F2—obesity	3.31e-06	9.49e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—BAD—obesity	3.27e-06	9.38e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKR1C3—obesity	3.27e-06	9.37e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CG—obesity	3.24e-06	9.28e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SCARB1—obesity	3.22e-06	9.22e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IRS1—obesity	3.2e-06	9.18e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC2A4—obesity	3.2e-06	9.16e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCG—obesity	3.2e-06	9.16e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.17e-06	9.09e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CG—obesity	3.17e-06	9.08e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYCS—obesity	3.15e-06	9.04e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	3.13e-06	8.98e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IRS1—obesity	3.13e-06	8.98e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SREBF1—obesity	3.12e-06	8.95e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GOT1—obesity	3.1e-06	8.87e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GGT1—obesity	3.1e-06	8.87e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—POMC—obesity	3.08e-06	8.84e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INS—obesity	3.07e-06	8.79e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NCOA1—obesity	3.05e-06	8.74e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GOT2—obesity	3.04e-06	8.71e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL2—obesity	3.02e-06	8.65e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—POMC—obesity	3.02e-06	8.64e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—STK11—obesity	3.01e-06	8.61e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP19A1—obesity	3.01e-06	8.61e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INS—obesity	3e-06	8.6e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3e-06	8.59e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—FASN—obesity	2.97e-06	8.52e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1—obesity	2.97e-06	8.5e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT2—obesity	2.96e-06	8.49e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—BCHE—obesity	2.96e-06	8.49e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL2—obesity	2.95e-06	8.46e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1—obesity	2.9e-06	8.31e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT2—obesity	2.9e-06	8.31e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2E1—obesity	2.86e-06	8.19e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CD—obesity	2.85e-06	8.16e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NQO1—obesity	2.82e-06	8.1e-05	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	2.82e-06	8.08e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SERPINE1—obesity	2.82e-06	8.07e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—COMT—obesity	2.79e-06	8.01e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CD—obesity	2.78e-06	7.98e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.77e-06	7.93e-05	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	2.76e-06	7.91e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GNB3—obesity	2.75e-06	7.9e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARGC1A—obesity	2.75e-06	7.9e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SERPINE1—obesity	2.75e-06	7.9e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMOX1—obesity	2.74e-06	7.86e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.74e-06	7.85e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TYK2—obesity	2.74e-06	7.85e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RHOA—obesity	2.72e-06	7.79e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC2A4—obesity	2.71e-06	7.76e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCG—obesity	2.71e-06	7.76e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOS3—obesity	2.69e-06	7.71e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3R1—obesity	2.69e-06	7.71e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GNAS—obesity	2.68e-06	7.69e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TYK2—obesity	2.68e-06	7.68e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYCS—obesity	2.67e-06	7.66e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RHOA—obesity	2.66e-06	7.62e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3R1—obesity	2.63e-06	7.54e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOS3—obesity	2.63e-06	7.54e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOB—obesity	2.63e-06	7.53e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GGT1—obesity	2.62e-06	7.52e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GOT1—obesity	2.62e-06	7.52e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NCOA1—obesity	2.58e-06	7.4e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	2.56e-06	7.34e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—STK11—obesity	2.55e-06	7.3e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP19A1—obesity	2.55e-06	7.3e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPL—obesity	2.51e-06	7.19e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	2.5e-06	7.18e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MTOR—obesity	2.48e-06	7.11e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CB—obesity	2.48e-06	7.11e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GPX1—obesity	2.45e-06	7.01e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MTOR—obesity	2.43e-06	6.96e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CB—obesity	2.43e-06	6.96e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CD36—obesity	2.38e-06	6.83e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—COMT—obesity	2.37e-06	6.78e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GNB3—obesity	2.33e-06	6.69e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARGC1A—obesity	2.33e-06	6.69e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMOX1—obesity	2.32e-06	6.66e-05	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—obesity	2.3e-06	6.6e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GNAS—obesity	2.27e-06	6.51e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—obesity	2.27e-06	6.5e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—obesity	2.26e-06	6.47e-05	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—obesity	2.25e-06	6.46e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOB—obesity	2.23e-06	6.38e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—obesity	2.22e-06	6.36e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARA—obesity	2.22e-06	6.35e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP9—obesity	2.16e-06	6.18e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AGT—obesity	2.15e-06	6.15e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPL—obesity	2.12e-06	6.09e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP9—obesity	2.11e-06	6.05e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOE—obesity	2.1e-06	6.03e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK8—obesity	2.1e-06	6.01e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—obesity	2.09e-06	6e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CAV1—obesity	2.08e-06	5.97e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA1—obesity	2.08e-06	5.96e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPX1—obesity	2.07e-06	5.94e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK8—obesity	2.05e-06	5.88e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—obesity	2.05e-06	5.87e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CD36—obesity	2.02e-06	5.79e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—STAT3—obesity	1.92e-06	5.5e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—obesity	1.91e-06	5.48e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CG—obesity	1.9e-06	5.44e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARA—obesity	1.88e-06	5.38e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—STAT3—obesity	1.88e-06	5.38e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—obesity	1.83e-06	5.25e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AGT—obesity	1.82e-06	5.21e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—POMC—obesity	1.81e-06	5.18e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INS—obesity	1.8e-06	5.15e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MYC—obesity	1.78e-06	5.11e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOE—obesity	1.78e-06	5.1e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFB1—obesity	1.78e-06	5.1e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CAV1—obesity	1.76e-06	5.06e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA1—obesity	1.76e-06	5.05e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MYC—obesity	1.74e-06	5e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFB1—obesity	1.74e-06	4.98e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.69e-06	4.83e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CD—obesity	1.67e-06	4.78e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—obesity	1.65e-06	4.72e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CG—obesity	1.61e-06	4.61e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3R1—obesity	1.57e-06	4.51e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NOS3—obesity	1.57e-06	4.51e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—obesity	1.55e-06	4.45e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—POMC—obesity	1.53e-06	4.39e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INS—obesity	1.52e-06	4.36e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CA—obesity	1.51e-06	4.34e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CA—obesity	1.48e-06	4.24e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CB—obesity	1.45e-06	4.17e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—obesity	1.44e-06	4.13e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CD—obesity	1.41e-06	4.05e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—obesity	1.39e-06	4e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—obesity	1.34e-06	3.84e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3R1—obesity	1.33e-06	3.82e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NOS3—obesity	1.33e-06	3.82e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—obesity	1.31e-06	3.76e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—obesity	1.24e-06	3.54e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CB—obesity	1.23e-06	3.53e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—obesity	1.22e-06	3.5e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—obesity	1.21e-06	3.47e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CA—obesity	8.86e-07	2.54e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CA—obesity	7.51e-07	2.15e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—obesity	7.24e-07	2.08e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—obesity	6.13e-07	1.76e-05	CbGpPWpGaD
